← Leaderboards
Joseph T Coyle
Harvard University (Medical School)
$14,085,663
Attributed
$14,085,663
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$29,509,439 · 14
By mechanism
P50$24,072,645 · 12
R01$5,002,294 · 1
R21$434,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- Roger D Spealman$14,290,245
- David L Paul$7,110,752
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaGlutamatesN-Methyl-D-Aspartate ReceptorsHippocampus (Brain)SymptomsCognitiveN-MethylaspartateAgonistBehavioralSerineSiteBrainGlycineMemoryReceptor FunctionImpaired CognitionFunctional DisorderNeurobehavioral ManifestationsIn VivoGenesAffectAnimalsMediatingSynapses
Grant awards (75)
Psychosis and Brain Glutamate$395,000
R01 · FY2017 · MH · contact PI
Psychosis and Brain Glutamate$395,000
R01 · FY2016 · MH · contact PI
Psychosis and Brain Glutamate$395,000
R01 · FY2015 · MH · contact PI
Psychosis and Brain Glutamate$395,000
R01 · FY2014 · MH · contact PI
Drug Abuse, Schizophrenia, NMDA Receptor$237,000
R21 · FY2014 · DA · contact PI
Psychosis and Brain Glutamate$379,200
R01 · FY2013 · MH · contact PI
Drug Abuse, Schizophrenia, NMDA Receptor$197,500
R21 · FY2013 · DA · contact PI
Psychosis and Brain Glutamate$395,000
R01 · FY2012 · MH · contact PI
Psychosis and Brain Glutamate$395,000
R01 · FY2011 · MH · contact PI
Glutamatergic Dysfunction and Schizophrenia$1,701,492
P50 · FY2010 · MH · contact PI
Mouse Models of NMDAR Hypofunction$304,491
P50 · FY2010 · MH · contact PI
Clinical Trials with Glutamatergic Agents$253,279
P50 · FY2010 · MH · contact PI
Dopamine and NMDA: role in novelty detection$252,790
P50 · FY2010 · MH · contact PI
NMDA hypofunction and episodic memory: An animal model$251,870
P50 · FY2010 · MH · contact PI
Functional MR of the Effects of D-Serine$248,539
P50 · FY2010 · MH · contact PI
Biomarkers of NMDA dysfunction and D-serine effects$237,557
P50 · FY2010 · MH · contact PI
BIOSTATISTICAL RESEARCH CORE$105,960
P50 · FY2010 · MH · contact PI
Computational Core$47,006
P50 · FY2010 · MH · contact PI
Glutamatergic Dysfunction and Schizophrenia$1,720,366
P50 · FY2009 · MH · contact PI
Psychosis and Brain Glutamate$321,603
R01 · FY2009 · MH · contact PI
Mouse Models of NMDAR Hypofunction$309,317
P50 · FY2009 · MH · contact PI
Dopamine and NMDA: role in novelty detection$256,797
P50 · FY2009 · MH · contact PI
NMDA hypofunction and episodic memory: An animal model$256,149
P50 · FY2009 · MH · contact PI
Clinical Trials with Glutamatergic Agents$254,749
P50 · FY2009 · MH · contact PI
Functional MR of the Effects of D-Serine$252,480
P50 · FY2009 · MH · contact PI
Biomarkers of NMDA dysfunction and D-serine effects$235,721
P50 · FY2009 · MH · contact PI
BIOSTATISTICAL RESEARCH CORE$107,643
P50 · FY2009 · MH · contact PI
Computational Core$47,510
P50 · FY2009 · MH · contact PI
Glutamatergic Dysfunction and Schizophrenia$1,717,112
P50 · FY2008 · MH · contact PI
Psychosis and Brain Glutamate$312,232
R01 · FY2008 · MH · contact PI
Mouse Models of NMDAR Hypofunction$307,751
P50 · FY2008 · MH · contact PI
Dopamine and NMDA: role in novelty detection$268,194
P50 · FY2008 · MH · contact PI
NMDA hypofunction and episodic memory: An animal model$255,431
P50 · FY2008 · MH · contact PI
Clinical Trials with Glutamatergic Agents$251,575
P50 · FY2008 · MH · contact PI
Functional MR of the Effects of D-Serine$250,445
P50 · FY2008 · MH · contact PI
Biomarkers of NMDA dysfunction and D-serine effects$229,637
P50 · FY2008 · MH · contact PI
BIOSTATISTICAL RESEARCH CORE$107,033
P50 · FY2008 · MH · contact PI
Computational Core$47,046
P50 · FY2008 · MH · contact PI
Glutamatergic Dysfunction and Schizophrenia$1,723,800
P50 · FY2007 · MH · contact PI
Mouse Models of NMDAR Hypofunction$314,782
P50 · FY2007 · MH · contact PI
Psychosis and Brain Glutamate$312,192
R01 · FY2007 · MH · contact PI
Dopamine and NMDA: role in novelty detection$268,760
P50 · FY2007 · MH · contact PI
NMDA hypofunction and episodic memory: An animal model$263,528
P50 · FY2007 · MH · contact PI
Functional MR of the Effects of D-Serine$250,343
P50 · FY2007 · MH · contact PI
Clinical Trials with Glutamatergic Agents$235,233
P50 · FY2007 · MH · contact PI
Biomarkers of NMDA dysfunction and D-serine effects$232,729
P50 · FY2007 · MH · contact PI
BIOSTATISTICAL RESEARCH CORE$109,466
P50 · FY2007 · MH · contact PI
Computational Core$48,959
P50 · FY2007 · MH · contact PI
Glutamatergic Dysfunction and Schizophrenia$1,877,599
P50 · FY2006 · MH · contact PI
Psychosis and Brain Glutamate$312,153
R01 · FY2006 · MH · contact PI
Mouse Models of NMDAR Hypofunction$276,909
P50 · FY2006 · MH · contact PI
NMDA hypofunction and episodic memory: An animal model$231,410
P50 · FY2006 · MH · contact PI
Dopamine and NMDA: role in novelty detection$229,481
P50 · FY2006 · MH · contact PI
Functional MR of the Effects of D-Serine$214,684
P50 · FY2006 · MH · contact PI
Biomarkers of NMDA dysfunction and D-serine effects$200,095
P50 · FY2006 · MH · contact PI
Collaboration with Project 2 and Project 3$190,199
P50 · FY2006 · MH · contact PI
Clinical Trials with Glutamatergic Agents$178,609
P50 · FY2006 · MH · contact PI
Administrative Core$114,754
P50 · FY2006 · MH · contact PI
BIOSTATISTICAL RESEARCH CORE$107,068
P50 · FY2006 · MH · contact PI
Computational Core$42,889
P50 · FY2006 · MH · contact PI
Apoptosis in GABA Cells in Hippocampal Circuitry$1
P50 · FY2006 · MH · contact PI
Psychosis and Brain Glutamate$325,605
R01 · FY2005 · MH
GLUTAMATERGIC DYSFUNCTION AND SCHIZOPHRENIA$1,362,988
P50 · FY2004 · MH
GLUTAMATERGIC DYSFUNCTION AND SCHIZOPHRENIA$1,332,874
P50 · FY2003 · MH
GLUTAMATERGIC DYSFUNCTION AND SCHIZOPHRENIA$1,045,223
P50 · FY2002 · MH
GLUTAMATERGIC DYSFUNCTION AND SCHIZOPHRENIA$297,017
P50 · FY2002 · MH
PSYCHOSIS AND BRAIN GLUTAMATE$228,612
R01 · FY2002 · MH
MOLECULAR CHARACTERIZATION OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II$0
P50 · FY2002 · MH
MOLECULAR CHARACTERIZATION OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II$0
P50 · FY2002 · MH
GLUTAMATERGIC DYSFUNCTION AND SCHIZOPHRENIA$1,316,436
P50 · FY2001 · MH
PSYCHOSIS AND BRAIN GLUTAMATE$223,049
R01 · FY2001 · MH
MOLECULAR CHARACTERIZATION OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II$0
P50 · FY2001 · MH
GLUTAMATERGIC DYSFUNCTION AND SCHIZOPHRENIA$1,328,869
P50 · FY2000 · MH
PSYCHOSIS AND BRAIN GLUTAMATE$217,648
R01 · FY2000 · MH
MOLECULAR CHARACTERIZATION OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II$0
P50 · FY2000 · MH